Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067938 · ClinicalTrials.gov registry record · Phase 4
Bipolar Study in Adults at Least 18 Years of Age
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,200
- Enrollment target
NCT00067938 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 1,200 participants.
The verdict
NCT00067938, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
Bipolar study of tolerability, clinical response and patient satisfaction
Interventions
- DRUG lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067938
The ClinicalTrials.gov registry entry for NCT00067938 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lamotrigine is the first listed.
NCT00067938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067938 about?
NCT00067938 is a clinical study titled "Bipolar Study in Adults at Least 18 Years of Age". Bipolar study of tolerability, clinical response and patient satisfaction
What is the current status of trial NCT00067938?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,200 participants. The study started on 2003-08. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00067938?
The interventions under investigation include: lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00067938?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.